Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D.G. Tishchenko
Validation of Predictive Pharmacoeconomic Model of Introduction of Medicinal Product Ibrutinib Into Chronic Lymphatic Leukemia Therapy Practice in the Territory of the Russian Federation
Pharmacoeconomics: theory and practice
Related publications
Toxocariasis: Current State of the Russian Federation Message 1: Risk of Toxocariasis Infection of the Population on the Territory of the Russian Federation
Epidemiology and Vaccine Prevention
Mechanism of State Regulation of Competitiveness of Tourist Territory Krasnodar Territory, Russian Federation
MATEC Web of Conferences
Materials Science
Engineering
Chemistry
Arresting the Inflammatory Drive of Chronic Lymphocytic Leukemia With Ibrutinib
Clinical Cancer Research
Cancer Research
Oncology
Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) With Nilotinib as the Second-Line Treatment in Russian Federation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Three Newly Approved Drugs for Chronic Lymphocytic Leukemia: Incorporating Ibrutinib, Idelalisib, and Obinutuzumab Into Clinical Practice
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
The Analysis of the Excise Taxes’ Use Concerning Goods Importation Into the Territory of the Russian Federation in Terms of the EAEU Membership
Izvestiya of Saratov University. New Series. Series Economics. Management. Law
Pharmacoeconomic Study of the Eliquis (Apixaban) Use Within the Program of Essential Medicines Provision in the Russian Federation
Medical Technologies. Assessment and Choice
Freedom of Assembly in the Practice of the Constitutional Court of the Russian Federation
RUDN Journal of Law
